Cargando…

PET Imaging Biomarkers of Anti-EGFR Immunotherapy in Esophageal Squamous Cell Carcinoma Models

Epidermal growth factor receptor (EGFR) is overexpressed and considered as a proper molecular target for diagnosis and targeted therapy of esophageal squamous cell carcinoma (ESCC). This study evaluated the usefulness of PET imaging biomarkers with (64)Cu-PCTA-cetuximab and (18)F-FDG-PET for anti-EG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Tae Sup, Song, In Ho, Shin, Jong Il, Park, Yong Serk, Kim, Jung Young, Kim, Kwang Il, Lee, Yong Jin, Kang, Joo Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262544/ https://www.ncbi.nlm.nih.gov/pubmed/30373221 http://dx.doi.org/10.3390/cells7110187

Ejemplares similares

Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model
por: Song, In Ho, et al.
Publicado: (2017)

Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles
por: Kim, Jung Seok, et al.
Publicado: (2018)

Therapeutic Response Monitoring with (89)Zr-DFO-Pertuzumab in HER2-Positive and Trastuzumab-Resistant Breast Cancer Models
por: Kang, Minwoo, et al.
Publicado: (2022)

Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma
por: Kim, Hyo Song, et al.
Publicado: (2015)

An Unusual Case of Submucosal Invasion of Esophageal Squamous Cell Carcinoma Mistaken as Primary Achalasia
por: Park, Jung Ho, et al.
Publicado: (2010)

E2/E6 ratio and L1 immunoreactivity as biomarkers to determine HPV16-positive high-grade squamous intraepithelial lesions (CIN2 and 3) and cervical squamous cell carcinoma
por: Choi, Youn-Jin, et al.
Publicado: (2018)

Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
por: Yun, Jae Kwang, et al.
Publicado: (2022)

A Case of Esophageal Squamous Papillomatosis
por: Park, Sang-Hyun, et al.
Publicado: (2012)

Perioperative immunotherapy for esophageal squamous cell carcinoma: Now and future
por: Liu, Yong
Publicado: (2023)

A Case of Esophageal Squamous Cell Carcinoma in situ Arising from Esophageal Squamous Papilloma
por: Cho, Jae Yeong, et al.
Publicado: (2019)

The Role of Adjuvant Chemotherapy after Neoadjuvant Chemoradiotherapy Followed by Surgery in Patients with Esophageal Squamous Cell Carcinoma
por: Park, Seong Yong, et al.
Publicado: (2023)

Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome
por: Lee, Jin Seo, et al.
Publicado: (2016)

A Large Cystic Phyllodes Tumor of the Prostate
por: Chung, Hyun Chul, et al.
Publicado: (2009)

Detection of metastatic tumors after γ-irradiation using longitudinal molecular imaging and gene expression profiling of metastatic tumor nodules
por: JANG, SU JIN, et al.
Publicado: (2016)

Deoxypodophyllotoxin, a Lignan from Anthriscus sylvestris, Induces Apoptosis and Cell Cycle Arrest by Inhibiting the EGFR Signaling Pathways in Esophageal Squamous Cell Carcinoma Cells
por: Kwak, Ah-Won, et al.
Publicado: (2020)

Immunotherapy for Esophageal Squamous Cell Carcinoma
por: Kojima, Takashi, et al.
Publicado: (2017)

The Role of One-Year Endoscopic Follow-Up for the Esophageal Remnant and Gastric Conduit after Esophagectomy with Gastric Reconstruction for Esophageal Squamous Cell Carcinoma
por: Park, Seong Yong, et al.
Publicado: (2013)

Implication of FDG-PET/CT without synchronous colonic lesion in patients with stenotic left-sided colorectal cancer
por: Lee, Jong Il, et al.
Publicado: (2021)

Long-term Outcomes and Factors Affecting the Survival of Patients with Mucosal Esophageal Squamous Cell Carcinoma
por: Kim, Ga Hee, et al.
Publicado: (2021)

Tumor Niche Network-Defined Subtypes Predict Immunotherapy Response of Esophageal Squamous Cell Cancer
por: Ko, Kyung-Pil, et al.
Publicado: (2023)

Biomarkers for immunotherapy in esophageal cancer
por: Wang, Xuelian, et al.
Publicado: (2023)

Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR‐tyrosine kinase inhibitor treatment response
por: Park, Ha Young, et al.
Publicado: (2016)

Immunotherapy for Squamous Esophageal Cancer: A Review
por: Petrillo, Angelica, et al.
Publicado: (2022)

Esophageal wound healing by aligned smooth muscle cell-laden nanofibrous patch
por: Yeo, Miji, et al.
Publicado: (2023)

The Prevalence and Clinical Characteristics of Esophageal Involvement in Patients with Behçet's Disease: A Single Center Experience in Korea
por: Yi, Seung Woo, et al.
Publicado: (2009)

Diagnostic and Predictive Values of (18)F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma
por: Hong, Il Ki, et al.
Publicado: (2020)

Urinary Nerve Growth Factor as a Potential Biomarker of Treatment Outcomes in Overactive Bladder Patients
por: Suh, Yoon Seok, et al.
Publicado: (2017)

Molecular genetic study of novel biomarkers for early diagnosis of oral squamous cell carcinoma
por: Yong-Deok, Kim, et al.
Publicado: (2015)

Metabolic parameters on baseline (18)F-FDG PET/CT are potential predictive biomarkers for immunotherapy in patients with head and neck squamous cell carcinoma
por: Kwon, Hye Ryeong, et al.
Publicado: (2022)

Intra-abdominal Esophageal Duplication Cyst in an Adult
por: Kim, Young Wan, et al.
Publicado: (2005)

Surgically resected T1‐ and T2‐stage esophageal squamous cell carcinoma: T and N staging performance of EUS and PET/CT
por: Jeong, Dong Young, et al.
Publicado: (2018)

Real-World Efficacy Data and Predictive Clinical Parameters for Treatment Outcomes in Advanced Esophageal Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Kim, Jwa Hoon, et al.
Publicado: (2022)

Comparable Clinical Outcome Using Small or Large Gross Tumor Volume-to-Clinical Target Volume Margin Expansion in Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
por: Lee, Tae Hoon, et al.
Publicado: (2022)

Identification of exon 19 and 21 mutations of EGFR gene in Chinese patients with esophageal squamous cell carcinoma
por: Cui, Yong, et al.
Publicado: (2013)

Comparison of neoadjuvant nab‐paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma
por: Yang, Yafan, et al.
Publicado: (2023)

Role of intraoperative feeding jejunostomy in esophageal cancer surgery
por: Kim, Min Soo, et al.
Publicado: (2022)

Potential Biomarkers for Diagnosis of Overactive Bladder Patients: Urinary Nerve Growth Factor, Prostaglandin E2, and Adenosine Triphosphate
por: Suh, Yoon Seok, et al.
Publicado: (2017)

The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2015)

In vivo monitoring of CD44(+) cancer stem-like cells by γ-irradiation in breast cancer
por: KIM, MI HYUN, et al.
Publicado: (2016)

Thyroid transcription factor-1 as a prognostic indicator for stage IV lung adenocarcinoma with and without EGFR-sensitizing mutations
por: Park, Ji Young, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vjendhgladpb9ono3qhmmolnkk